The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Phenobarbital Effects in Cholestatic Liver Disease
Abstract
Fifteen patients with cholestatic disorders were treated for 1 to 5 months with phenobarbital. Primary biliary cirrhosis was diagnosed in seven, sclerosing cholangitis in two, intrahepatic biliary hypoplasia in three, and cholestatic hepatitis in three. Except for the patients with cholestatic hepatitis, in whom marked cholestasis was virtually the only abnormality in liver biopsy specimens, serum bilirubin and bile acid concentrations were diminished during therapy, the hepatic clearance of sulfobromophthalein and 131-I-rose bengal was variably enhanced, and there was relief from pruritus. Serum cholesterol concentrations and other measures of hepatic function were not significantly changed during therapy except for serum alkaline phosphatase activity, which rose in twelve patients. Parallel changes occurred in 5'-nucleotidase, suggesting a hepatic origin for the alkaline phosphatase activity. These studies indicate that phenobarbital therapy is associated with improvement in organic anion clearance in some patients with cholestatic disorders and may be beneficial to such patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Phenobarbital can improve cholestatic pruritus but is a strong sedative that worsens or initiates fatigue, increases vitamin D deficiency, and has been associated with troublesome gingival hyperplasia.(213)”
From Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases (2019) · cites this paper as [213]
Citations
Cites
THE DETERMINATION OF BILIRUBIN WITH THE PHOTOELECTRIC COLORIMETER
Malloy, H. T., & Evelyn, K. A. (1937) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)74392-5 · Cited by 1,617
ADAPTIVE INCREASES IN DRUG-METABOLIZING ENZYMES INDUCED BY PHENOBARBITAL AND OTHER DRUGS
Conney, A. H., Davison, C., Gastel, R., & Burns, J. J. (1960) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)25856-6 · Cited by 533
EFFECT OF DRUGS ON THE FORMATION OF SMOOTH ENDOPLASMIC RETICULUM AND DRUG‐METABOLIZING ENZYMES
Remmer, H., & Merker, H. J. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb12247.x · Cited by 371
Effect of Chronic Anticonvulsant Therapy on Serum 25-Hydroxycalciferol Levels in Adults
Hahn, T. J., Hendin, B. A., Scharp, C. R., & Haddad, J. G. (1972) · New England Journal of Medicine · doi:10.1056/nejm197211022871803 · Cited by 354
Chronic nonhemolytic unconjugated hyperbilirubinemia with glucuronyl transferase deficiency
Arias, I. M., Gartner, L. M., Cohen, M., Ezzer, J. B., & Levi, A. J. (1969) · The American Journal of Medicine · doi:10.1016/0002-9343(69)90224-1 · Cited by 340
The role of the liver in drug metabolism
Remmer, H. (1970) · The American Journal of Medicine · doi:10.1016/s0002-9343(70)80129-2 · Cited by 226
Reyes, H., Levi, A. J., Gatmaitan, Z., & Arias, I. M. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106721 · Cited by 209
Mechanism of phenobarbital-induced hypercholeresis in the rat
Berthelot, P., Erlinger, S., Dhumeaux, D., & Preaux, A. (1970) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1970.219.3.809 · Cited by 207
Mitochondrial Antibody in Primary Biliary Cirrhosis and Other Diseases
KLATSKIN, G., & KANTOR, F. S. (1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-77-4-533 · Cited by 197
Orrenius, S., & Ericsson, J. L. E. (1966) · The Journal of Cell Biology · doi:10.1083/jcb.28.2.181 · Cited by 176
Research works printed but not linked: 4
- EARNEST D, 1972, Bile Acids in Human Diseases, 145
- BARBER-RILEY G, 1961, Clin Sci, 20, 149
- 10.1172/JCI107160 · DOI
- POPOVIC S, 1969, Clin Res, 17, 308
Cited by
Lindor, K. D., Bowlus, C. L., Boyer, J., Levy, C., & Mayo, M. (2019) · Hepatology · doi:10.1002/hep.30145 · Cited by 913
Self-citationCarey, E. J., Ali, A. H., & Lindor, K. D. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00154-3 · Cited by 735
Primary Sclerosing Cholangitis
Lee, Y.-M., & Kaplan, M. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321406 · Cited by 526
ACG clinical guideline: primary sclerosing cholangitis
Lindor, K. D., Kowdley, K. V., & Harrison, E. M. (2015) · American Journal of Gastroenterology · doi:10.1038/ajg.2015.112 · Cited by 524
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma
Bowlus, C. L., Arrivé, L., Bergquist, A., Deneau, M., Forman, L., Ilyas, S. I., Lunsford, K. E., Martinez, M., Sapisochin, G., Shroff, R., et al. (2023) · Hepatology · doi:10.1002/hep.32771 · Cited by 428
Metadata
- Authors
- BLOOMER, J. R., & BOYER, J. L.
- Corresponding author
- BLOOMER, JOSEPH R.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 1975-03-01
- Volume
- 82
- Issue
- 3
- Pages
- 310-317
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2157797819
- Cited by
- 120
- References
- 40
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 2 · 2018: 2 · 2017: 1 · 2016: 3 · 2015: 5 · 2014: 1 · 2013: 2 · 2012: 3
- FWCI
- 4.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Keywords
- phenobarbital, cholestatic liver disease, primary biliary cirrhosis, sclerosing cholangitis, cholestatic hepatitis, sulfobromophthalein, rose bengal, alkaline phosphatase, 5'-nucleotidase, pruritus, serum bilirubin, bile acids, serum cholesterol
- MeSH terms
- Adult, Bile Ducts, Intrahepatic, Bilirubin, Chenodeoxycholic Acid, Child, Child, Preschool, Cholangitis, Cholestasis, Cholic Acids, Feces, Female, Hepatitis, Humans, Liver, Liver Cirrhosis, Biliary, Liver Function Tests, Male, Middle Aged, Phenobarbital, Pruritus, Rose Bengal, Sulfobromophthalein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Phenobarbital Effects in Cholestatic Liver Disease. https://app.cochat.ai/papers/10.7326/0003-4819-82-3-310
- The paper
- BLOOMER, J. R., & BOYER, J. L. (1975). Phenobarbital Effects in Cholestatic Liver Disease. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-82-3-310
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.